Status:

UNKNOWN

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Prurigo Nodularis

Atopic Dermatitis

Eligibility:

All Genders

18+ years

Brief Summary

Prurigo nodularis (PN) is a skin condition characterized by symmetrically distributed widespread, pruritic nodules that occurs in patients with chronic pruritus. There are 2 subtypes of PN depending o...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • More than 18 years of age
  • Signature of the written contentment
  • Clinical diagnostic of PN defined by the following: a minimum of 20 PN lesions, in total on both legs, and/or both arms; an average worst itch score of ≥7. Atopic PN will be defined as PN associating clinical sings or history of AD according to Hanifin et Rajka criteria. Non-Atopic PN will be defined as PN non-associated with clinical sings or history of AD according to Hanifin et Rajka criteria.
  • or confirmed diagnosis of AD according to Hanifin et Rajka criteria without associated PN.
  • Washout period for topical treatments (\> 1 week) ans systemic treatments (\> 1 month).
  • Indication and absence of contraindication to performing a skin biopsy as part of the treatment
  • Inclusion criteria for healthy controls:
  • more than 18 years of age
  • Signature of the written contentment
  • Hospitalised in the plastic surgery department of Saint-Louis Hospital.
  • No associated inflammatory or tumoral skin condition
  • No contraindication for biopsy
  • Exclusion criteria :
  • Presence of inflammatory or tumoral skin morbidities other than PN and atopic dermatitis
  • Treatment induced pruritus
  • Pruritus secondary to other medical conditions such as bullous dermatosis, renal insufficiency, infectious diseases, …)
  • AD under biologic therapy
  • Patient under guardianship or conservatorship
  • No health insurance coverage
  • Patient under State Medical Assistance (AME)
  • Pregnancy or breastfeeding
  • Persons deprived of their liberty by a judicial or administrative decision
  • People undergoing psychiatric care making their consent impossible
  • Adults who are the subject of a legal protection measure or unable to express their consent
  • Patients unable to read and write
  • Exclusion criteria for healthy controls:
  • Inflammatory or tumoral medical condition
  • Biological therapy for any other medical condition
  • Associated inflammatory or tumoral skin condition
  • Pregnancy or breastfeeding
  • Persons deprived of their liberty by a judicial or administrative decision
  • People undergoing psychiatric care making their consent impossible
  • Adults who are the subject of a legal protection measure or unable to express their consent
  • Patients unable to read and write

Exclusion

    Key Trial Info

    Start Date :

    February 1 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 15 2021

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT04681300

    Start Date

    February 1 2021

    End Date

    July 15 2021

    Last Update

    February 9 2021

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.